A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies

Joint Authors

Wang, Hanyin
Tuncer, Hande

Source

Case Reports in Hematology

Issue

Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-4, 4 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2018-07-03

Country of Publication

Egypt

No. of Pages

4

Main Subjects

Diseases

Abstract EN

The value of combination therapy for refractory ITP is not well defined.

We present the case of a 29-year-old male with severe ITP refractory to initial standard therapy including steroids, IVIG, and subsequent splenectomy, who was treated with the combination therapy of rituximab, romiplostim, and mycophenolate and eventually developed thrombocytosis requiring plateletpheresis.

Our case highlights the importance of the need to understand predictors of response to standard upfront treatment of acute ITP.

American Psychological Association (APA)

Wang, Hanyin& Tuncer, Hande. 2018. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies. Case Reports in Hematology،Vol. 2018, no. 2018, pp.1-4.
https://search.emarefa.net/detail/BIM-1144057

Modern Language Association (MLA)

Wang, Hanyin& Tuncer, Hande. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies. Case Reports in Hematology No. 2018 (2018), pp.1-4.
https://search.emarefa.net/detail/BIM-1144057

American Medical Association (AMA)

Wang, Hanyin& Tuncer, Hande. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies. Case Reports in Hematology. 2018. Vol. 2018, no. 2018, pp.1-4.
https://search.emarefa.net/detail/BIM-1144057

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1144057